Assessment of IL_6 and IL_34 Serum in Patients with Diabetic Foot Ulcers

Authors

  • Sarah Zghair Hussein College of Applied Medical Sciences, Al-Muthanna University, IRAQ.
  • Raghad H. Al-azzawi Department of Biology, College of Science, Baghdad University, Baghdad, IRAQ.

DOI:

https://doi.org/10.55544/sjmars.4.4.10

Keywords:

Diabetic foot ulcers, IL_6, IL_34, Demographic data, Sandwich ELISA

Abstract

Diabetes foot ulcers (DFUs) are serious vascular pathological effects related to diabetes mellitus. Interleukins are a subclass of cytokines represent a diverse category of signaling particles which adjust cellular activities. Interleukin-6 (IL-6), a central cytokine in acute inflammatory reaction, stimulating liver to produce acute phase proteins and contributing to the progress of diabetes. Recently, recognized pro-inflammatory cytokine interleukin-34 (IL)-34 binds to colony stimulating factor-1(CSF-1) receptor and is implicated in pathogenesis of different chronic inflammatory and autoimmune conditions. This study aimed to estimate serum concentrations of IL-6 and IL-34 in diabetic individuals with DFUs compared to healthy controls. The research, conducted from January to July 2022 at Al-Hussein Teaching Hospital in Samawa/Iraq, Medical city/Baghdad Hospital in Baghdad/ Iraq. The study was conducted on two groups: 140 DFUs patients and 70 control group. The age range of DFUs patients was 29–87 years, whereas of control group was 18–57 years. The levels of serum IL-6 and IL-34 were evaluation using sandwich ELISA technique. The average random blood sugar level in patients was 226.9 mg/dL. The findings shown that DFUs were significantly associated with factors (P value ˂ 0.05) were: 93(66.4%) are male, high 79(56.40%) are within (31-60) year, smoking 50 (35.7%), overweight 55 (39.3%), type 2 DM 131(93.6%). Similarly, results revealed a significant elevation in IL-6 and IL-34 levels in DEUs individuals compared to control group (P ≤ 0.05).

References

[1] Hussein, S. Z., and Saleh, G. M. Molecular Detection of Virulence Factors Genes for Staphylococcus aureus in Diabetic Foot Ulcers in Iraq. Ibn AL-Haitham Journal for Pure and Applied Sciences, (2024) 37(3), 98-105.‏ DOI: https://doi.org/10.30526/37.3.3431

[2] Syafril, S. Pathophysiology diabetic foot ulcer. In IOP Conference Series: Earth and Environmental Science (2018, March) (Vol. 125, No. 1, p. 012161). IOP Publishing.‏ DOI: 10.1088/1755-1315/125/1/012161

[3] Monteiro‐Soares, M., Boyko, E. J., Jeffcoate, W., Mills, J. L., Russell, D., Morbach, S., and Game, F. Diabetic foot ulcer classifications: a critical review. Diabetes/metabolism research and reviews, (2020) 36, e3272.‏ https://doi.org/10.1002/dmrr.3272

[4] Mohammed, H., and Salloom, D. F. Evaluation of interleukin-9 serum level and gene polymorphism in a sample of Iraqi type 2 diabetic mellitus patients. Meta Gene, (2021) 27, 100845.‏ https://doi.org/10.1016/j.mgene.2020.100845

[5] Khalil, Z. K. Uropathogenic Infections among Patients with Diabetes in Baghdad City. Iraqi Journal of Science, (2016) 57(1B), 360-366.‏

[6] Al-Attaby, A. K. T., and Al-Lami, M. Q. D. Role of calcium-regulating hormones, adipocytokines and renal function test in the progress of type 2 diabetes mellitus in a sample of Iraqi patients. The Iraqi Journal of Agricultural Science, (2019) 50(1), 343-351.‏

[7] Al-Musawi, H. S., Al-Lami, M. Q., and Al-Saadi, A. H. Age and gender impact on glycaemic control, renal function and oxidative stress parameters in Iraqi patients type 2 diabetes mellitus. Biochem. Cell. Arch, (2021) 21(1), 491-499.‏ https://connectjournals.com/03896.2021.21.491

[8] Stojkov, D., Gigon, L., Peng, S., Lukowski, R., Ruth, P., Karaulov, A., and Simon, H. U. Physiological and pathophysiological roles of metabolic pathways for NET formation and other neutrophil functions. Frontiers in immunology, (2022) 13.‏ https://doi.org/10.3389/fimmu.2022.826515

[9] Baqer, N. N., Saheb, E. J., Ahmed, N. S., and Alhadad, N. A. A. The association of IL-3, IL-17A, and IL 27 serum levels with susceptibility to toxoplasmosis in recurrent abortion of Iraqi women. Experimental Parasitology, (2022) 234, 108217.‏ https://doi.org/10.1016/j.exppara.2022.108217

[10] Nussrat, S. W., and Ad'hiah, A. H. Interleukin‐39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index. Endocrinology, Diabetes & Metabolism, (2023) e409.‏ https://doi.org/10.1002/edm2.409

[11] Melekoglu, R., Ciftci, O., Celik, E., Yilmaz, E., and Bastemur, A. G. Evaluation of second trimester amniotic fluid ADAMTS4, ADAMTS5, interleukin‐6 and tumor necrosis factor‐α levels in patients with gestational diabetes mellitus. Journal of Obstetrics and Gynaecology Research, (2019) 45(4), 824-829.‏ https://doi.org/10.1111/jog.13914

[12] Tahir, N. T., Abdulsattar, S. A., and Alkazzaz, F. F. Assessment of Obesity, Dyslipidemia, Hyperglycemia, and Pro-Inflammatory Cytokines as Cardiovascular Disease Risk Factors in Acromegaly Patients. Baghdad Science Journal, (2022) 19(5), 0976-0976.‏ https://doi.org/10.21123/bsj.2022.6002

[13] Akbari, M., and Hassan-Zadeh, V. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology, (2018) 26(3), 685-698.‏ https://doi.org/10.1007/s10787-018-0458-0

[14] Li, X., Lu, Y., and Wei, P. Association between VEGF genetic variants and diabetic foot ulcer in Chinese Han population: a case–control study. Medicine, (2018) 97(20).‏ DOI: 10.1097/MD.0000000000010672

[15] Malta, D. C., Duncan, B. B., Schmidt, M. I., Machado, Í. E., Silva, A. G. D., Bernal, R. T. I., and Szwarcwald, C. L. Prevalence of diabetes mellitus as determined by glycated hemoglobin in the Brazilian adult population, National Health Survey. Revista Brasileira De Epidemiologia, (2019) 22.‏ https://doi.org/10.1590/1980-549720190006.supl.2

[16] McDonald, R. P. Factor analysis and related methods. (2014) Psychology Press.‏ https://doi.org/10.4324/9781315802510

[17] Fawzy, M. S., Alshammari, M. A., Alruwaili, A. A., Alanazi, R. T., Alharbi, J. A., Almasoud, A. M. R., and Toraih, E. A. Factors associated with diabetic foot among type 2 diabetes in Northern area of Saudi Arabia: a descriptive study. BMC research notes, (2019) 12(1), 1-7.‏ https://doi.org/10.1186/s13104-019-4088-4

[18] Musa, I. R., Ahmed, M. O., Sabir, E. I., Alsheneber, I. F., Ibrahim, E. M., Mohamed, G. B., and Gasim, G. I. Factors associated with amputation among patients with diabetic foot ulcers in a Saudi population. BMC research notes, (2018) 11(1), 1-5.‏ https://doi.org/10.1186/s13104-018-3372-z

[19] Guo, Q., Ying, G., Jing, O., Zhang, Y., Liu, Y., Deng, M., and Long, S. Influencing factors for the recurrence of diabetic foot ulcers: A meta‐analysis. International wound journal, (2023) 20(5), 1762-1775.‏ https://doi.org/10.1111/iwj.14017

[20] Huang, Z. H., Li, S. Q., Kou, Y., Huang, L., Yu, T., and Hu, A. Risk factors for the recurrence of diabetic foot ulcers among diabetic patients: a meta‐analysis. International Wound Journal, (2019) 16(6), 1373-1382.‏ https://doi.org/10.1111/iwj.13200

[21] Marzoq, A., Shiaa, N., Zaboon, R., Baghlany, Q., and Alabbood, M. H. Assessment of the outcome of diabetic foot ulcers in Basrah, Southern Iraq: A cohort study. Dubai Diabetes and Endocrinology Journal, (2019) 25(1-2), 33-38.‏ https://doi.org/10.1159/000500911

[22] Korkmaz, P., Koçak, H., Onbaşı, K., Biçici, P., Özmen, A., Uyar, C., & Özatağ, D. M. The role of serum procalcitonin, interleukin‐6, and fibrinogen levels in differential diagnosis of diabetic foot ulcer infection. Journal of diabetes research, (2018) 2018(1), 7104352.‏ https://doi.org/10.1155/2018/7104352

[23] Kagwa, G. H., Amugune, B. K., Menge, T. B., and Nyamu, D. G. Antimicrobial susceptibility of bacteria that infect diabetic foot ulcers at Kenyatta National Hospital, Kenya African Journal of Pharmacology and Therapeutics, (2018) 7(2).

[24] Khalifa, W. A. Risk factors for diabetic foot ulcer recurrence: a prospective 2-year follow-up study in Egypt. The Foot, (2018) 35, 11-15.‏ https://doi.org/10.1016/j.foot.2017.12.004

[25] Yazdanpanah, L., Shahbazian, H., Nazari, I., Arti, H. R., Ahmadi, F., Mohammadianinejad, S. E., and Hesam, S. Incidence and risk factors of diabetic foot ulcer: a population‐based diabetic foot cohort (ADFC study)—two‐year follow‐up study. International journal of endocrinology, (2018) 2018(1), 7631659.‏ https://doi.org/10.1155/2018/7631659

[26] Seghieri, G., Policardo, L., Gualdani, E., Anichini, R., and Francesconi, P. Gender difference in the risk for cardiovascular events or mortality of patients with diabetic foot syndrome. Acta Diabetologica, (2019) 56(5), 561-567.‏ https://doi.org/10.1007/s00592-019-01292-y

[27] Navarro-Flores, E., and Cauli, O. Quality of life in individuals with diabetic foot syndrome. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders), (2020) 20(9), 1365-1372.‏ https://doi.org/10.2174/1871530320666200128154036

[28] Eltilib, A. A. E. Association between smoking and foot ulcer among patients with diabetes mellitus, Wad Medani, Sudan. Sudan Journal of Medical Sciences, (2021) 16(4), 450-463.‏ DOI: 10.18502/sjms.v16i4.9943

[29] Mariam, T. G., Alemayehu, A., Tesfaye, E., Mequannt, W., Temesgen, K., Yetwale, F., and Limenih, M. A. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow‐up clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: institutional‐based cross‐sectional study. Journal of diabetes research, (2017) 2017(1), 2879249. https://doi.org/10.1155/2017/2879249

[30] Zhang, P., Lu, J., Jing, Y., Tang, S., Zhu, D., and Bi, Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of medicine, (2017) 49(2), 106-116. ‏https://doi.org/10.1080/07853890.2016.1231932

[31] Costa, R. H. R., Cardoso, N. A., Procópio, R. J., Navarro, T. P., Dardik, A., and de Loiola Cisneros, L. Diabetic foot ulcer carries high amputation and mortality rates, particularly in the presence of advanced age, peripheral artery disease and anemia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, (2017) 11, S583-S587.‏ https://doi.org/10.1016/j.dsx.2017.04.008

[32] Lee, Y. J., Han, K. D., and Kim, J. H. Association among Current Smoking, Alcohol Consumption, Regular Exercise, and Lower Extremity Amputation in Patients with Diabetic Foot: Nationwide Population-Based Study. Endocrinology and Metabolism, (2022) 37(5), 770-780. https://doi.org/10.3803/EnM.2022.1519

[33] Sohn, M. W., Budiman‐Mak, E., Lee, T. A., Oh, E., and Stuck, R. M. Significant J‐shaped association between body mass index (BMI) and diabetic foot ulcers. Diabetes/metabolism research and reviews, (2011) 27(4), 402-409.‏ https://doi.org/10.1002/dmrr.1193

[34] Hussein, F., Shabbir, M., Bunyad, S., Arshad, F., Kashif, M., and Siddique, J. Diabetic Foot Ulcers: Prevalence and Associated Risk Factors Among Diabetic Patients: Diabetic Foot Ulcers. Pakistan Journal of Health Sciences, (2022) 86-90.‏ https://doi.org/10.54393/pjhs.v3i05.241

[35] Pitocco, D., Spanu, T., Di Leo, M., Vitiello, R., Rizzi, A., Tartaglione, L., and Sanguinetti, M. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci, (2019) 23(2 Suppl), 26-37.‏

[36] Jalilian, M., Sarbarzeh, P. A., and Oubari, S. Factors related to severity of diabetic foot ulcer: a systematic review. Diabetes, metabolic syndrome and obesity: targets and therapy, (2020) 13, 1835-1842. https://doi.org/10.2147/DMSO.S256243

[37] Madmoli, M., Madmoli, Y., Taqvaeinasab, H., Khodadadi, M., Darabiyan, P., and Rafi, A. Some influential factors on severity of diabetic foot ulcers and Predisposing of limb amputation: A 7-year study on diabetic patients. International Journal of Ayurvedic Medicine, (2019) 10(1), 75-81.‏

[38] Sen, P., Demirdal, T., and Emir, B. Meta‐analysis of risk factors for amputation in diabetic foot infections. Diabetes/metabolism research and reviews, (2019) 35(7), e3165. https://doi.org/10.1002/dmrr.3165 ‏

[39] Welty, F. K., Alfaddagh, A., and Elajami, T. K. Targeting inflammation in metabolic syndrome. Translational research, (2016) 167(1), 257-280.‏ https://doi.org/10.1016/j.trsl.2015.06.017

[40] Zorena, K., Jachimowicz-Duda, O., Ślęzak, D., Robakowska, M., and Mrugacz, M. Adipokines and obesity. Potential link to metabolic disorders and chronic complications. International journal of molecular sciences, (2020) 21(10), 3570.‏ https://doi.org/10.3390/ijms21103570

[41] Lee, E. G., Luckett-Chastain, L. R., Calhoun, K. N., Frempah, B., Bastian, A., & Gallucci, R. M. Interleukin 6 function in the skin and isolated keratinocytes is modulated by hyperglycemia. Journal of immunology research, (2019) 2019(1), 5087847.‏ https://doi.org/10.1155/2019/5087847

[42] Chandrika, A. M. Dr. VS Kalai Selvi, Significance Of Interleukin-6 In Diabetes Mellitus And Its Complications. (2022). Int. J. Life Sci. Pharma Res, (2022) 12(1), L170-174. 10.22376/ijpbs/lpr.2022.12.1.L170-174

[43] Al-Salih, R. M., and Ali, Z. M. Relations between interleukin-6 and some biochemical parameters in diabetic foot syndrome. Prof.(Dr) RK Sharma, (2021) 21(1), 1230.‏

[44] Zorena, K., Jachimowicz-Duda, O., and Wąż, P. The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications. Biomarkers, (2016) 21(3), 276-282.‏ https://doi.org/10.3109/1354750X.2016.1138321

[45] Chang, E. J., Lee, S. K., Song, Y. S., Jang, Y. J., Park, H. S., Hong, J. P., and Heo, Y. S. IL-34 is associated with obesity, chronic inflammation, and insulin resistance. The Journal of Clinical Endocrinology & Metabolism, (2014) 99(7), E1263-E1271.‏ https://doi.org/10.1210/jc.2013-4409

[46] Anegon, I. Carole Guillonneau, Séverine Bézie &. Cell. Mol. Life Sci, (2017) 74, 2569-2586.‏ DOI: 10.1007/s00018-017-2482-4

[47] Piao, C., Wang, X., Peng, S., Guo, X., Zhao, H., He, L., and Wang, Y. IL-34 causes inflammation and beta cell apoptosis and dysfunction in gestational diabetes mellitus. Endocrine Connections, (2019) 8(11), 1503-1512.‏ https://doi.org/10.1530/EC-19-0436

Downloads

Published

2025-08-31

How to Cite

Zghair Hussein, S., & H. Al-azzawi, R. (2025). Assessment of IL_6 and IL_34 Serum in Patients with Diabetic Foot Ulcers. Stallion Journal for Multidisciplinary Associated Research Studies, 4(4), 80–87. https://doi.org/10.55544/sjmars.4.4.10

Issue

Vol. 4 No. 4 (2025): August Issue

Section

Articles

License

Copyright (c) 2025 Stallion Journal for Multidisciplinary Associated Research Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.